Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. (Q33899971)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
scientific article

    Statements

    Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit